TD Asset Management
IMRX icon

TD Asset Management’s Immuneering IMRX Stock Holding History

TD Asset Management’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$497K Sell
94,340
-23,506
-20% -$121K ﹤0.01% 1171
2025
Q4 		$775K Sell
117,846
-27,334
-19% -$175K ﹤0.01% 1129
2025
Q3 		$1.02M Buy
+145,180
New +$753K ﹤0.01% 1087
2025
Q2 		– Sell
-71,066
Closed -$108K – 1223
2025
Q1 		$108K Sell
71,066
-79,810
-53% -$145K ﹤0.01% 1208
2024
Q4 		$332K Hold
150,876
– – ﹤0.01% 1205
2024
Q3 		$401K Hold
150,876
– – ﹤0.01% 1319
2024
Q2 		$193K Hold
150,876
– – ﹤0.01% 1342
2024
Q1 		$436K Sell
150,876
-47,000
-24% -$263K ﹤0.01% 1315
2023
Q4 		$1.45M Sell
197,876
-86,600
-30% -$577K ﹤0.01% 1097
2023
Q3 		$2.18M Buy
284,476
+142,238
+100% +$1.31M ﹤0.01% 931
2023
Q2 		$1.44M Sell
142,238
-1,865
-1% -$17.9K ﹤0.01% 1042
2023
Q1 		$1.4M Sell
144,103
-2,611
-2% -$14.8K ﹤0.01% 1076
2022
Q4 		$712K Sell
146,714
-947
-0.6% -$8.39K ﹤0.01% 1209
2022
Q3 		$1.94M Hold
147,661
– – ﹤0.01% 1013
2022
Q2 		$799K Buy
147,661
+26,460
+22% +$141K ﹤0.01% 1217
2022
Q1 		$784K Buy
121,201
+86,905
+253% +$835K ﹤0.01% 1273
2021
Q4 		$555K Hold
34,296
– – ﹤0.01% 1369
2021
Q3 		$911K Buy
+34,296
New +$922K ﹤0.01% 1274

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TD Asset Management's IMRX Position: Q1 2026 in Review

TD Asset Management reduced its Immuneering (IMRX) stake by 20% in Q1 2026, selling an estimated $121K and leaving 94,340 shares worth $497K. The position accounts for ﹤0.01% of the portfolio, ranked #1171.

TD Asset Management first reported a position in IMRX in Q3 2021 and has held it in 18 quarters since. The position peaked at $2.18M in Q3 2023. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • TD Asset Management held 94,340 shares of Immuneering worth $497K as of Q1 2026.
  • TD Asset Management sold 23,506 Immuneering shares in Q1 2026, an estimated $121K.
  • Immuneering made up ﹤0.01% of TD Asset Management's portfolio in Q1 2026, its #1171 holding.
  • TD Asset Management first reported a position in Immuneering in Q3 2021 and has held it in 18 quarters since.
  • TD Asset Management's Immuneering position peaked at $2.18M in Q3 2023.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.